Peter J. Crowley
Peter Crowley joined WindRose Health Investors in 2011 as an Operating Partner. Additionally, since April 2008, Mr. Crowley has been an operating partner at JH Partners, a private equity firm managing close to $1 billion of institutional funds. Mr. Crowley has been involved with JH for over ten years as a both a director of portfolio companies and an investor. JH Partners currently owns over twenty companies in the consumer and luxury goods sectors. Mr. Crowley retired from CIBC World Markets in April of 2008. Mr. Crowley spent 23 years at CIBC World Markets, the last fourteen as global head of healthcare investment banking. As global head of healthcare Mr. Crowley was involved in over five hundred transactions and over $30 billion of capital raised and transactions consummated. Transactions include public and private equity and debt financing’s and mergers and acquisitions transactions for biotechnology, pharmaceutical, medical devices, healthcare services and healthcare technology companies. Mr. Crowley was also heavily involved with the healthcare principal investments made by CIBC Capital Partners. Prior to CIBC Mr. Crowley worked for Allen & Company in venture capital and Blyth Eastman Paine Webber in mergers and acquisitions.
Mr. Crowley is a board member of the Foundation Fighting Blindness. He is also on the board of the following private companies: Anabios, Celerion, Lykan Bioscience, Veristat and Ouidad and is the Chairman of the public company Progenics Pharmaceuticals. He is a committee member of the Harvard Alumni Association and member of the council of Rockefeller University.
Mr. Crowley graduated from Harvard College in 1981 and received an M.B.A. from Columbia University in 1985.